|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2008-10-20
|
|
pubmed:abstractText |
PCA3 is a prostate specific, nonprotein coding RNA that is over expressed in prostate cancer. Recent studies showed the diagnostic potential of a urine based PCA3 for predicting biopsy outcome. We assessed the relationship between urine PCA3 and pathological features in whole mount radical prostatectomy specimens.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1527-3792
|
|
pubmed:author |
pubmed-author:AliAminaA,
pubmed-author:BlaseAmyA,
pubmed-author:BrassellStephenS,
pubmed-author:ChenYongmeiY,
pubmed-author:CullenJenniferJ,
pubmed-author:ElsamanoudiSallyS,
pubmed-author:FurusatoBungoB,
pubmed-author:GroskopfJackJ,
pubmed-author:IbrahimMonaM,
pubmed-author:McLeodDavid GDG,
pubmed-author:PetrovicsGyorgyG,
pubmed-author:RittenhouseHarryH,
pubmed-author:SesterhennIsabell AIA,
pubmed-author:SrivastavaShivS,
pubmed-author:WhitmanEric JEJ
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
180
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1975-8; discussion 1978-9
|
|
pubmed:dateRevised |
2009-12-11
|
|
pubmed:meshHeading |
pubmed-meshheading:18801539-Adult,
pubmed-meshheading:18801539-Aged,
pubmed-meshheading:18801539-Analysis of Variance,
pubmed-meshheading:18801539-Antigens, Neoplasm,
pubmed-meshheading:18801539-Biopsy, Needle,
pubmed-meshheading:18801539-Cohort Studies,
pubmed-meshheading:18801539-Digital Rectal Examination,
pubmed-meshheading:18801539-Humans,
pubmed-meshheading:18801539-Immunohistochemistry,
pubmed-meshheading:18801539-Logistic Models,
pubmed-meshheading:18801539-Male,
pubmed-meshheading:18801539-Middle Aged,
pubmed-meshheading:18801539-Multivariate Analysis,
pubmed-meshheading:18801539-Neoplasm Invasiveness,
pubmed-meshheading:18801539-Neoplasm Staging,
pubmed-meshheading:18801539-Predictive Value of Tests,
pubmed-meshheading:18801539-Preoperative Care,
pubmed-meshheading:18801539-Probability,
pubmed-meshheading:18801539-Prognosis,
pubmed-meshheading:18801539-Prostate-Specific Antigen,
pubmed-meshheading:18801539-Prostatectomy,
pubmed-meshheading:18801539-Prostatic Neoplasms,
pubmed-meshheading:18801539-RNA, Messenger,
pubmed-meshheading:18801539-ROC Curve,
pubmed-meshheading:18801539-Risk Assessment,
pubmed-meshheading:18801539-Survival Rate,
pubmed-meshheading:18801539-Treatment Outcome,
pubmed-meshheading:18801539-Tumor Burden,
pubmed-meshheading:18801539-Tumor Markers, Biological
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volume.
|
|
pubmed:affiliation |
Urology Service, Walter Reed Army Medical Center, Washington, DC 20307, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
